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Background:  Since the risk for all-cause mortality, and thereby the risk for sudden cardiac death, increases with age, the superior effect of 
prophylactic ICD treatment might be higher in older patients as compared to younger patients. However, elderly have higher in-hospital mortality 
following ICD implantation, are underrepresented in clinical trials and available data regarding benefit of the ICD are inconsistent. The aim of the 
study was to assess the influence of age on ICD treatment in the elderly.
Methods:  All patients treated with an ICD for primary prevention of sudden cardiac death at the Leiden University Medical Center from January 
1996 to January 2009 were included and allocated to 3 groups according to age. Endpoints consisted of appropriate shocks (delivered for 
ventricular tachycardia and ventricular fibrillation) and survival gain. Survival gain was defined as the hypothetical life prolongation after termination 
of the first ventricualr arrhythmia by the ICD.
Results:  Patient cohort consisted of 1395 consecutive primary prevention ICD patients with ischemic and nonischemic cardiomyopathy (mean 
age 63±11 years, 79% male) and comprised 705 patients (51%) aged <65 years, 493 patients (35%) aged 65-74 years and 197 patients (14%) 
aged ≥75 years. Mean follow-up was 2.9±2.1 years. Five-year cumulative incidence of appropriate shocks was 19% for patients <65 years, 23% for 
patients 65-74 years and 13% for patients ≥75 years (p=0.47). At 1-year following appropriate shock, cumulative incidence for death was 35% for 
patients ≥75 years as compared to 7% for patients <65 years (p<0.05).
Conclusion: Despite experiencing similar rates of appropriate ICD shocks, more than one-third of patients ≥75 years has died within one year after 
receiving appropriate shocks as compared to only 7% of patients <65 years.
